We offer this innovative treatment to help patients achieve their weight loss goals alongside better blood sugar control
A separate Phase 2 trial in Lancet (Rosenstock et al., 2023) tested retatrutide in 281 adults with type 2 diabetes and showed HbA1c reduction plus 16.94% weight loss at 36 weeks in the highest studied arm
As scientific understanding of obesity continues to improve, future treatments may offer even more personalized approaches for helping individuals achieve sustainable weight loss and better overall health
Comparing Inno Gut Protect and Ozempic Weight Loss Efficacy Inno Gut Protect : Uses natural gut-loving compounds to stimulate GLP-1 production, leading to gradual and sustainable weight loss
Some weeks show no loss despite perfect adherence
general injectable peptide principles suggest refrigeration, protection from light, and avoidance of freezing, but trial-specific instructions must always take precedence